Patents by Inventor Niclas Bengtsson

Niclas Bengtsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170362635
    Abstract: Pharmaceutical compositions including a muscle-specific nuclease cassette, one or more guide RNA cassettes, and a delivery system for delivery of the muscle-specific nuclease cassette and the one or more gRNA cassettes are provided. The pharmaceutical composition may also include a mutation-corrected DNA template including a modification to be made in a target nucleic acid sequence. Methods for treating a subject having a muscular or neuromuscular disorder are also provided. The methods may include administering to the subject a therapeutically effective amount of the pharmaceutical composition. Methods of modifying or editing the sequence of a target nucleic acid sequence in a muscle cell are also provided. The methods may include contacting or transducing the muscle cell with a muscle-specific nuclease cassette and one or more gRNA cassettes.
    Type: Application
    Filed: June 20, 2017
    Publication date: December 21, 2017
    Applicant: University of Washington
    Inventors: Jeffrey S. Chamberlain, Niclas Bengtsson, Stephen D. Hauschka
  • Patent number: 8617522
    Abstract: Multimodal nanoparticles are nanoparticles containing contrast agents for PAT and one or more of luminescence imaging, x-ray imaging, and/or MRI. The multimodal nanoparticles can have a dielectric core comprising an oxide with a metal coating on the core. The particles can be metal speckled. The multimodal nanoparticles can be used for therapeutic purposes such as ablation of tumors or by neutron capture in addition to use as contrast agents for imaging.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: December 31, 2013
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Parvesh Sharma, Brij M. Moudgil, Glenn A. Walter, Stephen R. Grobmyer, Swadeshmukul Santra, Huabei Jiang, Scott Chang Brown, Edward W. Scott, Qizhi Zhang, Niclas Bengtsson
  • Publication number: 20130108552
    Abstract: The subject invention provides novel fluorescent core-shell nanoparticles comprising an encapsulated fluorescent core comprising an ionically bound fluorescent dye and a metal oxide shell. In one exemplary embodiment of the invention a core containing indocyanine green (ICG) with a silica shell that displays excellent photostability for generation of a near infrared fluorescence signal. The fluorescent core-shell nanoparticle can be further modified to act as an MRI, x-ray, or PAT contrast agent. The ICG nanoparticles can also be used as photodynamic therapeutic agent. Other embodiments of the invention directed to methods of making the novel core-shell nanoparticles and to the use of the core-shell nanoparticles for in vitro or in vivo imaging.
    Type: Application
    Filed: February 24, 2011
    Publication date: May 2, 2013
    Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC.
    Inventors: Parvesh Sharma, Scott Chang Brown, Niclas Bengtsson, Glenn A. Walter, Nobutaka Iwakuma, Edward W. Scott, Stephen R. Grobmyer, Swadeshmukul Santra, Brij M. Moudgil
  • Patent number: 8361437
    Abstract: Multimodal nanoparticles are nanoparticles containing contrast agents for PAT and one or more of luminescence imaging, x-ray imaging, and/or MRI. The multimodal nanoparticles can have a dielectric core comprising an oxide with a metal coating on the core. The particles can be metal speckled. The multimodal nanoparticles can be used for therapeutic purposes such as ablation of tumors or by neutron capture in addition to use as contrast agents for imaging.
    Type: Grant
    Filed: August 28, 2008
    Date of Patent: January 29, 2013
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Parvesh Sharma, Brij M. Moudgil, Glenn A. Walter, Stephen R. Grobmyer, Swadeshmukul Santra, Huabei Jiang, Scott Chang Brown, Edward W. Scott, Qizhi Zhang, Niclas Bengtsson
  • Publication number: 20100254911
    Abstract: Multimodal nanoparticles are nanoparticles containing contrast agents for PAT and one or more of luminescence imaging, x-ray imaging, and/or MRI. The multimodal nanoparticles can have a dielectric core comprising an oxide with a metal coating on the core. The particles can be metal speckled. The multimodal nanoparticles can be used for therapeutic purposes such as ablation of tumors or by neutron capture in addition to use as contrast agents for imaging.
    Type: Application
    Filed: August 28, 2008
    Publication date: October 7, 2010
    Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC.
    Inventors: Parvesh Sharma, Brij M. Moudgil, Glenn A. Walter, Stephen R. Grobmyer, Swadeshmukul Santra, Huabei Jiang, Scott Chang Brown, Edward W. Scott, Qizhi Zhang, Niclas Bengtsson